Zobrazeno 1 - 3
of 3
pro vyhledávání: '"V. O. Shipunova"'
Autor:
O. V. Shlepova, M. A. Shulepko, V. O. Shipunova, M. L. Bychkov, I. D. Kukushkin, I. A. Chulina, V. N. Azev, E. I. Shramova, V. A. Kazakov, A. M. Ismailova, Y. A. Palikova, V. A. Palikov, E. A. Kalabina, E. A. Shaykhutdinova, G. A. Slashcheva, E. A. Tukhovskaya, I. A. Dyachenko, A. N. Murashev, S. M. Deyev, M. P. Kirpichnikov, Z. O. Shenkarev, E. N. Lyukmanova
Publikováno v:
Frontiers in Cell and Developmental Biology, Vol 11 (2023)
α7-Type nicotinic acetylcholine receptor (α7-nAChR) promotes the growth and metastasis of solid tumors. Secreted Ly6/uPAR-Related Protein 1 (SLURP-1) is a specific negative modulator of α7-nAChR produced by epithelial cells. Here, we investigated
Externí odkaz:
https://doaj.org/article/68ca419785d04cd79f6b4a41671b974e
Autor:
R. S. Kalinin, V. O. Shipunova, Y. P. Rubtsov, V. M. Ukrainskay, A. Schulga, E. V. Konovalova, D. V. Volkov, I. A. Yaroshevich, A. M. Moysenovich, A. A. Belogurov, G. B. Telegin, A. S. Chernov, M. A. Maschan, S. S. Terekhov, V. D. Knorre, E. Khurs, N. V. Gnuchev, A. G. Gabibov, S. M. Deyev
Publikováno v:
Doklady Biochemistry and Biophysics. 508:17-20
Abstract The development of CAR-T specific therapy made a revolution in modern oncology. Despite the pronounced therapeutic effects, this novel approach displayed several crucial limitations caused by the complications in pharmacokinetics and pharmac
Autor:
V O, Shipunova, S M, Deyev
Publikováno v:
Acta Naturae. 14:54-72
The use of traditional tools for the targeted delivery of nanostructures, such as antibodies, transferrin, lectins, or aptamers, often leads to an entire range of undesirable effects. The large size of antibodies often does not allow one to reach the